Bia Separations

 
BIA Separations, recently acquired by Sartorius, develops and manufactures market-leading CIM® monolithic chromatographic columns for purification and analysis of large biomolecules, such as viruses, plasmids and mRNA, which are applied in cell and gene therapies.  BIA's technology for manufacturing-scale purification is already used in production of the first commercialized advanced therapeutics; BIA also has a keen presence with novel drug candidates in the clinical pipeline.  Expecting continued strong double-digit sales growth over the next few years, BIA earned sales revenue approx. 25 million Euros in 2020, contributing to Sartorius Bioprocess Solutions, part of the Sartorius Group.
 

Contact us

BIA Separations, part of Sartorius
Mirce 21
5270 Ajdovščina
Slovenia
 
Phone: 00386 59 699 500
Email: sales@biaseparations.com
Website: www.biaseparations.com
 

Please go to
Live Stream Platform